Submissions
GlyTouCan
Glycan Structure Repository
GlyComb
Glycoconjugate Repository
GlycoPOST
Glycomics MS raw data Repository
UniCarb-DR
Glycomics MS Repository for glycan annotations from GlycoWorkbench
LM-GlycoRepo
Repository for lectin-assisted multimodality data
All Resources
Genes / Proteins / Lipids Glycans / Glycoconjugates Glycomes Pathways / Interactions / Diseases / OrganismsTools
SugarDrawer
GlycanBuilder
Glycan Converters
GlycoMaple
GlycomeAtlas
LM-GlycomeAtlas
GALAXY
MCAW
GlycoSim
GRable
Guidelines
MIRAGE
G61418DU
Summary
- GlyTouCan ID
-
G61418DU
- IUPAC Condensed
- GalNAc(b1-
Organisms
| Organisms | Evidence |
|---|---|
| Escherichia coli | |
| Rattus | |
| Cricetulus griseus (Chinese hamster) |
Taxonomic Hierarchy
GlycoGene Database (GGDB)
G01534TU
| Gene Symbol | Donor | Acceptor | Reducing terminal(Acceptor) | Reference |
|---|---|---|---|---|
| B4GALT3 | UDP-Gal |
G61418DU
|
4-Me-lumbelyl-[beta] | |
| B4GALT2 | UDP-Gal |
G61418DU
|
4-Me-lumbelyl-[beta] | |
| B4GALT3 | UDP-Gal |
G61418DU
|
o-Nitrophenyl-[beta] | |
| B4GALT7 | UDP-Gal |
G61418DU
|
4-D-MethylUmb-[beta] | |
| B4GALT4 | UDP-Gal |
G61418DU
|
[beta]-1-o-Nitrophenyl |
Pathway
| Pathway Name | Organism |
|---|---|
| E.coli O102 | Escherichia coli |
| E.coli O104 | Escherichia coli |
| E.coli O107 | Escherichia coli |
| E.coli O11 | Escherichia coli |
| E.coli O112ab | Escherichia coli |
| E.coli O112ac | Escherichia coli |
| E.coli O117 | Escherichia coli |
| E.coli O120 | Escherichia coli |
| E.coli O124 | Escherichia coli |
| E.coli O125ab | Escherichia coli |
Sequence Descriptors
- GlycoCT
-
RES 1b:b-dgal-HEX-1:5 2s:n-acetyl LIN 1:1d(2+1)2n
- WURCS
- WURCS=2.0/1,1,0/[a2112h-1b_1-5_2*NCC/3=O]/1/
Literature
| PubMed ID | Title | First Author | Publication Date | Source |
|---|---|---|---|---|
| 38348876 | A combinatorial approach for achieving CNS-selective RNAi | Ferguson CM | 2024 Feb 13 |
|
| 38227794 | Safety and Tolerability of GalNAc3-Conjugated Antisense Drugs Compared to the Same-Sequence 2′-O-Methoxyethyl-Modified Antisense Drugs: Results from an Integrated Assessment of Phase 1 Clinical Trial Data | Baker BF | 2024 Feb 01 |
|
| 39177802 | Givosiran for the Treatment of Pediatric Acute Intermittent Porphyria | Bujold KE | 2024 Aug 22 |
|
| 39145804 | Biosynthesis of animal-free recombinant chondroitin sulfate E using a functional chondroitin sulfotransferase in E. coli | Tithi AD | 2024 Aug 15 |
|
| 39126245 | O-GlcNAcylation determines the function of the key O-GalNAc glycosyltransferase C1GalT1 in bladder cancer | Jiang Y | 2024 Aug 01 |
|
| 38667801 | Chemical Synthesis of Fucosylated Chondroitin Sulfate Tetrasaccharide with Fucosyl Branch at the 6-OH of GalNAc Residue | Lv C | 2024 Apr 19 |
|
| 38479165 | Research progress on asialoglycoprotein receptor-targeted radiotracers designed for hepatic nuclear medicine imaging | Hua Y | 2024 Apr 05 |
|
| 38570436 | Cross-Reactive Polyclonal Antibodies Raised Against GalNAc-Conjugated siRNA Recognize Mostly the GalNAc Moiety | Ballman KK | 2024 Apr 03 |
|
| 38401583 | Deficiency of polypeptide N-acetylgalactosamine transferase 9 contributes to a risk for Parkinson's disease via mitochondrial dysfunctions | Peng Y | 2024 Apr |
|
| 38708485 | Recovery of chronic motor neuropathy due to acute intermittent porphyria after givosiran treatment in a young boy: a case report | Mazzoli M | 2024 Apr |
|
